Abstract View

Author(s): Dr. Sundhararajan R1, L K. Dhivya*2, Mohan. N3, Paul Christober. M4, Surya Prakash. S5, Tamil selvan. P6

Email(s): 1lkdhivya97@gmail.com

Address:

    Mohammed Sathak College of Pharmacy, Chennai, Tamilnadu

Published In:   Volume - 5,      Issue - 2,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5207  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Ethanolic extract of Euphorbia hirta where evaluated for their carbohydrate enzyme inhibition, it is the key indicator for anti-diabetic potential. The inhibitory activity of EEEH against carbohydrate-digesting enzymes was evaluated and compared with the standard drug acarbose. EEEH exhibited moderate α-amylase inhibitory activity, with an IC₅₀ value of 1.16 mg/mL, indicating measurable enzyme suppression. In comparison, acarbose demonstrated significantly stronger inhibition, as reflected by a lower IC₅₀ value of 0.42 mg/mL. The inhibitory activity of EEEH against α-glucosidase was evaluated and compared with the standard drug acarbose. EEEH exhibited moderate α-glucosidase inhibitory activity, with an IC₅₀ value of 1.21 mg/mL, indicating appreciable enzyme suppression. In contrast, acarbose showed stronger inhibitory potential, as evidenced by a lower IC₅₀ value of 0.44 mg/mL.

Cite this article:
Dr. Sundhararajan R, L K. Dhivya*, Mohan. N, Paul Christober. M, Surya Prakash. S, Tamil selvan. Evaluation of In-vitro Anti-diabetic activity in Ethanolic Stem Extract of Euphobia hirta. IJRPAS, February 2026; 5(2): 88-92.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5207


1.Kausar, J.; Muthumani, D.; Hedina, A.; Ramasamy, S.; Anand, V. Review of the phytochemical and

   pharmacological activities of Euphorbia hirta Linn. Pharmacogn. J. 2016, 8, 310–313. [CrossRef]

2. Sharma, M.; Sheliya, M.A.; Begum, R.; Pillai, K.K.; Aeri, V.; Mir, S.R.; Ali, A.; Sharma, M. In vitro

    α-glucosidase and α-amylase inhibition by aqueous, hydroalcoholic, and alcoholic extract of Euphorbia hirta L. Drug Dev. Ther. 2016, 7, 26. [CrossRef]

3.Sharma, N.K.; Dey, S.; Prasad, R. In vitro antioxidant potential evaluation of Euphorbia hirta L.

    Pharmacologyonline 2007, 1, 91–98.

4. Kumar, S.; Malhotra, R.; Kumar, D. Euphorbia hirta: Its chemistry, traditional and medicinal uses,

    and pharmacological activities. Pharmacogn. Rev. 2010, 4, 58–61. [CrossRef]

5. Tran, N.; Tran, M.; Truong, H.; Le, L. Spray-Drying Microencapsulation of High Concentration of Bioactive Compounds Fragments from Euphorbia hirta L. Extract and Their Effect on Diabetes Mellitus. Foods 2020, 9, 881. [CrossRef]

6. McCue P.P and Shetty, K. “Inhibitory effects of rosmarinic acid extracts on porcine pancreatic

    amylase in vitro,” Asia Pacific Journal of Clinical Nutrition, vol. 13, no. 1, pp. 101–106, 2004.

Related Images:



Recent Images



Evaluation of In-Vitro Anti-Diabetic Activity And   Antioxidant Activity In Ethanolic and Hydroalcoholic Extract of leaves of Gymnema Sylvestre
Molecular Docking Approaches in Antibacterial Drug Discovery: Computational Insights into Natural Compounds
In-vitro Evaluation of Anti-Urolithiatic Activity of Hydroalcoholic Extract of Centella asiatica Leaves
Quality by Design (Qbd) Based Method Development and Validation of Trelagliptin Succinate byu RP-HPLC.
Cubosomes: Structure, Preparation Methods, Characterization, and Pharmaceutical Applications
Programmable Oral Drug Delivery Systems: Materials, Device Engineering, Stimuli-Responsive Mechanisms, and Clinical Translation
Biomimetic Nanocarrier for Targeted Drug Delivery: An Integrated Review
From Phosphate Wasting to Targeted Therapy: An Updated Review of FGF23-Mediated Hypophosphatemic Rickets
Nanotechnology-Based Drug Delivery Systems for Alzheimer’s Disease: Emerging Strategies for Blood–Brain Barrier Targeting
Explainable AI in Pharmacy: Building Trust in AI-Based Drug Recommendation

Tags